Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009 Jul 23; 361(4):358-67.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.